Variant report
Variant | rs72828038 |
---|---|
Chromosome Location | chr17:33893908-33893909 |
allele | A/C |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | TBL1XR1 | chr17:33893875-33894266 | K562 | blood: | n/a | n/a |
2 | POLR2A | chr17:33893781-33895854 | K562 | blood: | n/a | n/a |
3 | IRF1 | chr17:33893787-33894223 | K562 | blood: | n/a | chr17:33893894-33893905 chr17:33893893-33893907 chr17:33893889-33893903 |
4 | POLR2A | chr17:33893879-33894261 | K562 | blood: | n/a | n/a |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:33893824..33895905-chr17:56735136..56737065,2 | MCF-7 | breast: | |
2 | chr17:33891810..33896606-chr17:33903023..33907452,11 | MCF-7 | breast: | |
3 | chr17:33893246..33896592-chr17:33904977..33907170,4 | MCF-7 | breast: | |
4 | chr17:33892195..33894200-chr17:34134782..34137507,2 | K562 | blood: | |
5 | chr17:33893761..33897248-chr17:33899377..33902990,5 | MCF-7 | breast: | |
6 | chr17:33891678..33894359-chr17:33894876..33897610,2 | MCF-7 | breast: | |
7 | chr17:33886372..33890944-chr17:33891247..33895229,11 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000267625 | TF binding region |
ENSG00000267321 | TF binding region |
ENSG00000172660 | Chromatin interaction |
ENSG00000207297 | Chromatin interaction |
ENSG00000108733 | Chromatin interaction |
ENSG00000267321 | Chromatin interaction |
ENSG00000267578 | Chromatin interaction |
ENSG00000267625 | Chromatin interaction |
ENSG00000006125 | Chromatin interaction |
ENSG00000202077 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10438814 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs1080352 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs11080356 | 0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11652234 | 0.82[AMR][1000 genomes];0.92[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs1634683 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs17550632 | 0.96[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17550716 | 0.90[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs178736 | 0.83[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225244 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225246 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225248 | 0.80[EUR][1000 genomes] |
rs225249 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225250 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225252 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225256 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225257 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225258 | 0.83[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225260 | 0.82[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs225261 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225264 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225265 | 0.83[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225266 | 0.87[ASN][1000 genomes] |
rs225267 | 0.82[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225268 | 0.81[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225270 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs225271 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs225274 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs225275 | 0.82[ASN][1000 genomes] |
rs225276 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs225278 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs225279 | 0.82[ASN][1000 genomes] |
rs225283 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225285 | 0.87[ASN][1000 genomes] |
rs225286 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225287 | 0.83[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225288 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225294 | 0.83[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225296 | 0.83[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225298 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225300 | 0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs225303 | 0.84[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225305 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225307 | 0.83[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs225308 | 0.83[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs226084 | 0.81[EUR][1000 genomes] |
rs226087 | 0.81[EUR][1000 genomes] |
rs226089 | 0.81[EUR][1000 genomes] |
rs226090 | 0.81[EUR][1000 genomes] |
rs2376177 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2428464 | 0.81[EUR][1000 genomes] |
rs2523114 | 0.81[EUR][1000 genomes] |
rs2523116 | 0.81[EUR][1000 genomes] |
rs2626625 | 0.81[EUR][1000 genomes] |
rs2626626 | 0.81[EUR][1000 genomes] |
rs35542792 | 0.84[AMR][1000 genomes];0.97[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs3859282 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs3859284 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs4796098 | 0.85[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs4796100 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs4796101 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs6505484 | 0.82[ASN][1000 genomes] |
rs6505485 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs6505486 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs6505487 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs7208672 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs7210966 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs7211724 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs7213804 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs7214250 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs7214742 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs7217378 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs7221203 | 0.81[EUR][1000 genomes] |
rs7405825 | 0.86[AMR][1000 genomes];0.92[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs8064895 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs8071584 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs8072676 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs8074800 | 0.82[ASN][1000 genomes] |
rs8077826 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs9303690 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs9894813 | 0.86[ASN][1000 genomes] |
rs9912939 | 0.81[EUR][1000 genomes];0.82[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv534371 | chr17:33456878-34094068 | Strong transcription Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 137 gene(s) | inside rSNPs | diseases |
2 | nsv908079 | chr17:33849869-34034851 | Active TSS Strong transcription Flanking Active TSS Enhancers Weak transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 44 gene(s) | inside rSNPs | diseases |
3 | nsv1060890 | chr17:33884124-34011034 | Weak transcription Flanking Active TSS Active TSS Enhancers Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 40 gene(s) | inside rSNPs | diseases |
4 | nsv543318 | chr17:33884124-34011034 | Genic enhancers Strong transcription Flanking Active TSS Weak transcription Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 40 gene(s) | inside rSNPs | diseases |
5 | nsv960465 | chr17:33891831-33894995 | Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Weak transcription Bivalent Enhancer | TF binding regionCpG islandChromatin interactive region | 11 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:33888600-33894200 | Weak transcription | Primary hematopoietic stem cells | blood |
2 | chr17:33889600-33894000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr17:33889800-33894000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr17:33893600-33894200 | Flanking Active TSS | K562 | blood |
5 | chr17:33893800-33894000 | Enhancers | Dnd41 | blood |